Existe-t-il des arguments pour contre-indiquer une hormonotherapie substitutive apres traitement d'un adenocarcinome ovarien?

Translated title of the contribution: Are there any arguments to contraindicate hormone substitution after treatment of ovarian adenocarcinoma?

Catherine Lhommé, Suzette Delaloge, Emmanuel Gonçalves, Virginia Taléa, Patricia Pautier

Research output: Contribution to journal › Article › peer-review

Translated title of the contribution	Are there any arguments to contraindicate hormone substitution after treatment of ovarian adenocarcinoma?
Original language	French
Pages (from-to)	706-713
Number of pages	8
Journal	Reproduction Humaine et Hormones
Volume	11
Issue number	9
Publication status	Published - 1 Oct 1998

Cite this

@article{67c5405d85094565a5904e44d6de93d7,

title = "Existe-t-il des arguments pour contre-indiquer une hormonotherapie substitutive apres traitement d'un adenocarcinome ovarien?",

author = "Catherine Lhomm{\'e} and Suzette Delaloge and Emmanuel Gon{\c c}alves and Virginia Tal{\'e}a and Patricia Pautier",

year = "1998",

month = oct,

day = "1",

language = "Fran{\c c}ais",

volume = "11",

pages = "706--713",

journal = "Reproduction Humaine et Hormones",